The absence of TRPML1 with low- or high-expressing TRPML2 reduced the OS of GBM patients, whereas high or low TRPML1 expression showed a protective effect by increased the OS in high-expressing TRPML2 GBM patients. This evidence concerns the gene MCOLN1 and glioblastoma.